ESAB's top-line acceleration to 12.9% YoY in 2026Q2, driven by a $1.5B acquisition, signals strategic expansion, but the concurrent 54.1% EPS decline and operating margin drop to 9.7% highlight integration and cost challenges.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth accelerated to 12.9% YoY in 2026Q2, but EPS fell 54.1% to $0.50, with operating margin compressing to 9.7% from 16.2% a year earlier, indicating that top-line gains are not translating into profitability.
ESAB's strategic pivot to medical gas systems and automation solutions positions it for sustained organic growth and margin expansion.
Increased infrastructure spending is driving demand for ESAB's core welding products, supporting revenue growth.
Recent acquisitions are expected to enhance cross-selling opportunities, further driving revenue and profitability.
Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 4, 2026 | $1.30-2.3% vs $1.33 | $825M+4.8% vs $787M |
Q3 2026 Aug 6, 2026 | $1.33-2.2% vs $1.36 | $808M+6.9% vs $756M |
Q2 2026 May 7, 2026 | $1.31-0.8% vs $1.32 | $746M+5.5% vs $707M |
Q1 2026 Feb 20, 2026 | $1.35+0.7% vs $1.34 | $688M-0.0% vs $688M |
ESAB NYSE: ESAB reported higher third-quarter sales and adjusted earnings before interest, taxes, depreciation and amortization, helped by acquisitions and organic growth in both of its reporting segments. The company also updated its full-year outlook and said it expects a stronger fourth quarter.
ESAB Corporation (ESAB) Q3 2026 Earnings Call Transcript
Esab (ESAB) came out with quarterly earnings of $1.3 per share, missing the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.32 per share a year ago.
NORTH BETHESDA, Md.--(BUSINESS WIRE)---- $ESAB #ESAB--ESAB Corporation Announces Third Quarter 2026 Results.
Benchmark ESAB against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for ESAB Corporation (ESAB)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $82.83 | $5.04B | 22.27 | 3.71% | 7.98% | 11.28% | 0.43% | |
| $280.95 | $80.83B | 26.78 | 0.92% | 19.39% | 103.35% | 2.17% | |
| $515.25 | $238.35B | 35.32 | 2.97% | 19.45% | 17.47% | 1.16% | |
| $209.90 | $10.05B | 636.06 | 2.49% | -0.63% | -0.78% | 0.29% | |
| $474.45 | $15.01B | 52.19 | 14.34% | 17.51% | 10.39% | — | |
| $341.97 | $11.82B | 15.39 | -2.73% | 13.76% | 60.1% | 1.44% |
ESAB Corporation (ESAB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
ESAB Corporation (ESAB) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
Jun 12, 2026·SEC
Jun 2, 2026·SEC
Get notified when ESAB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ESAB Corporation (ESAB) stock FAQ — growth, dividends, profitability & financials explained
ESAB Corporation (ESAB) reported $3.00B in revenue over the trailing twelve months. Revenue was $2.84B in fiscal year 2025. That is 27% more than the $2.25B of fiscal year 2019.
ESAB Corporation (ESAB) grew revenue by 3.7% in fiscal year 2025, compared with the prior fiscal year.
Yes. ESAB Corporation (ESAB) earned $172.5M in net income over the trailing twelve months (a 5.7% net margin).
Yes. ESAB Corporation (ESAB) pays a dividend that yields 0.43% at the current price, a small yield.
ESAB Corporation (ESAB) had a return on equity (ROE) of 11.3% in fiscal year 2025. That is in line with the market's typical 10-15%.
ESAB Corporation (ESAB) generated $196.6M in free cash flow over the trailing twelve months.
